Innoviva (INVA) Interest Expenses (2010 - 2026)
Innoviva posted quarterly Interest Expenses of $5.4 million for Q1 2026, up 15.41% year-on-year from $4.7 million in Q1 2025, and up 35.42% on a QoQ basis from $4.0 million in Q3 2025.
Innoviva (INVA) has 17 years of Interest Expenses data on file, last reported at $5.4 million in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses rose 15.41% year-over-year to $5.4 million; the trailing twelve-month figure through Mar 2026 stood at $14.1 million (down 13.51% YoY), and the FY2025 full-year result was $16.7 million, down 24.81% from the prior year.
- Interest Expenses for Q1 2026 stood at $5.4 million, up from $4.0 million in the prior quarter.
- Across five years, Interest Expenses topped out at $5.9 million in Q1 2024 and bottomed at $3.0 million in Q1 2022.
- The 5-year median for Interest Expenses is $4.7 million (2025), against an average of $4.7 million.
- The widest annual swing landed in 2022, when Interest Expenses plunged 35.88%; it then jumped 47.08% in 2023.
- A 5-year view of Interest Expenses shows it stood at $5.1 million in 2022, then declined by 13.74% to $4.4 million in 2023, then surged by 32.1% to $5.8 million in 2024, then slumped by 30.86% to $4.0 million in 2025, then surged by 35.42% to $5.4 million in 2026.
- The last three Interest Expenses figures came in at $5.4 million (Q1 2026), $4.0 million (Q3 2025), and $4.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 22,854.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -5.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 61,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -332,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 69.29 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 5.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.44 Mn |
| Mar 31, 2026 | 5.44 Mn |
| Sep 30, 2025 | 4.02 Mn |
| Sep 30, 2025 | 4.02 Mn |
| Jun 30, 2025 | 4.66 Mn |
| Jun 30, 2025 | 4.66 Mn |
| Mar 31, 2025 | 4.71 Mn |
| Mar 31, 2025 | 4.71 Mn |
| Sep 30, 2024 | 5.81 Mn |
| Sep 30, 2024 | 5.81 Mn |
| Jun 30, 2024 | 5.80 Mn |
| Jun 30, 2024 | 5.80 Mn |
| Mar 31, 2024 | 5.85 Mn |
| Mar 31, 2024 | 5.85 Mn |
| Sep 30, 2023 | 4.40 Mn |
| Sep 30, 2023 | 4.40 Mn |
| Jun 30, 2023 | 4.38 Mn |
| Jun 30, 2023 | 4.38 Mn |
| Mar 31, 2023 | 4.43 Mn |
| Mar 31, 2023 | 4.43 Mn |
| Sep 30, 2022 | 5.10 Mn |
| Sep 30, 2022 | 5.10 Mn |
| Jun 30, 2022 | 3.66 Mn |
| Jun 30, 2022 | 3.66 Mn |
| Mar 31, 2022 | 3.01 Mn |
| Mar 31, 2022 | 3.01 Mn |
| Sep 30, 2021 | 4.79 Mn |
| Sep 30, 2021 | 4.79 Mn |
| Jun 30, 2021 | 4.75 Mn |
| Jun 30, 2021 | 4.75 Mn |
| Mar 31, 2021 | 4.69 Mn |
| Mar 31, 2021 | 4.69 Mn |
| Dec 31, 2020 | 4.65 Mn |
| Dec 31, 2020 | 4.65 Mn |
| Sep 30, 2020 | 4.60 Mn |
| Sep 30, 2020 | 4.60 Mn |
| Jun 30, 2020 | 4.56 Mn |
| Jun 30, 2020 | 4.56 Mn |
| Mar 31, 2020 | 4.52 Mn |
| Mar 31, 2020 | 4.52 Mn |
| Dec 31, 2019 | 4.69 Mn |
| Dec 31, 2019 | 4.69 Mn |
| Sep 30, 2019 | 4.69 Mn |
| Sep 30, 2019 | 4.69 Mn |
| Jun 30, 2019 | 4.66 Mn |
| Jun 30, 2019 | 4.66 Mn |
| Mar 31, 2019 | 4.62 Mn |
| Mar 31, 2019 | 4.62 Mn |
| Dec 31, 2018 | 4.58 Mn |
| Dec 31, 2018 | 4.58 Mn |
| Sep 30, 2018 | 5.24 Mn |
| Sep 30, 2018 | 5.24 Mn |
| Jun 30, 2018 | 6.48 Mn |
| Jun 30, 2018 | 6.48 Mn |
| Mar 31, 2018 | 7.66 Mn |
| Mar 31, 2018 | 7.66 Mn |
| Dec 31, 2017 | 36.49 Mn |
| Dec 31, 2017 | 36.49 Mn |
| Sep 30, 2017 | 6.37 Mn |
| Sep 30, 2017 | 6.37 Mn |
| Jun 30, 2017 | 12.20 Mn |
| Jun 30, 2017 | 12.20 Mn |
| Mar 31, 2017 | 12.78 Mn |
| Mar 31, 2017 | 12.78 Mn |
| Dec 31, 2016 | 13.00 Mn |
| Dec 31, 2016 | 13.00 Mn |
| Sep 30, 2016 | 13.10 Mn |
| Sep 30, 2016 | 13.10 Mn |
| Jun 30, 2016 | 13.16 Mn |
| Jun 30, 2016 | 13.16 Mn |
| Mar 31, 2016 | 13.16 Mn |
| Mar 31, 2016 | 13.16 Mn |
| Dec 31, 2015 | 13.05 Mn |
| Dec 31, 2015 | 13.05 Mn |
| Sep 30, 2015 | 13.06 Mn |
| Sep 30, 2015 | 13.06 Mn |
| Jun 30, 2015 | 12.99 Mn |
| Jun 30, 2015 | 12.99 Mn |
| Mar 31, 2015 | 12.71 Mn |
| Mar 31, 2015 | 12.71 Mn |
| Dec 31, 2014 | 12.57 Mn |
| Dec 31, 2014 | 12.57 Mn |
| Sep 30, 2014 | 12.36 Mn |
| Sep 30, 2014 | 12.36 Mn |
| Jun 30, 2014 | 10.33 Mn |
| Jun 30, 2014 | 10.33 Mn |
| Mar 31, 2014 | 1.64 Mn |
| Mar 31, 2014 | 1.64 Mn |
| Dec 31, 2013 | 1.69 Mn |
| Dec 31, 2013 | 1.69 Mn |
| Sep 30, 2013 | 1.90 Mn |
| Sep 30, 2013 | 1.90 Mn |
| Jun 30, 2013 | 3.03 Mn |
| Jun 30, 2013 | 3.03 Mn |
| Mar 31, 2013 | 2.74 Mn |
| Mar 31, 2013 | 2.74 Mn |
| Dec 31, 2012 | 1.50 Mn |
| Dec 31, 2012 | 1.50 Mn |
| Sep 30, 2012 | 1.50 Mn |
| Sep 30, 2012 | 1.50 Mn |
| Jun 30, 2012 | 1.50 Mn |
| Jun 30, 2012 | 1.50 Mn |
| Mar 31, 2012 | 1.50 Mn |
| Mar 31, 2012 | 1.50 Mn |
| Dec 31, 2011 | 1.50 Mn |
| Dec 31, 2011 | 1.50 Mn |
| Sep 30, 2011 | 1.51 Mn |
| Sep 30, 2011 | 1.51 Mn |
| Jun 30, 2011 | 1.51 Mn |
| Jun 30, 2011 | 1.51 Mn |
| Mar 31, 2011 | 1.51 Mn |
| Mar 31, 2011 | 1.51 Mn |
| Dec 31, 2010 | 1.51 Mn |
| Dec 31, 2010 | 1.51 Mn |
| Sep 30, 2010 | 1.51 Mn |
| Sep 30, 2010 | 1.51 Mn |
| Jun 30, 2010 | 1.51 Mn |
| Jun 30, 2010 | 1.51 Mn |